Journal of Clinical Endocrinology & Metabolism, Vol 70, 1124-1131, Copyright © 1990 by Endocrine Society

ARTICLES

Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women

LS Myers, J Dixen, D Morrissette, M Carmichael and JM Davidson
Department of Physiology, Stanford University, California 94305-5070.

To assess the contribution of gonadal steroids to sexual behavior in aging women, we conducted a 10-week, double-blind, hormone replacement study of 40 naturally menopausal women (mean age, 58.3 yr). Prospective measurements of basal and stimulated vaginal vasocongestion and daily self-reports of mood, physical symptoms, sexual behavior, and perceived sexual pleasure were collected. Daily treatments were either conjugated equine estrogen, i.e. Premarin (P; 0.625 mg), Premarin and medroxyprogesterone acetate, i.e. Provera (PP; 0.625 and 5 mg, respectively), Premarin and methyltestosterone (PT; 0.625 and 5 mg, respectively), or placebo (PL). Compared to placebo, hormone treatment had significantly reduced hot flashes in the P and PP groups by week 4 and in the PT group by week 5. Headaches were reduced in the P vs. PL group, only. Hormone treatment did not significantly alter mood ratings, sexual behaviors, or psychophysiologically measured sexual arousal. PT treatment significantly increased reports of pleasure from masturbation compared to the other three groups, underscoring the apparent contribution of androgens to self-stimulatory behavior. However, the data suggest that in these physically and sexually healthy women, gonadal steroids do not influence major components of sexual functioning, including arousal and a wide variety of sexual activity and experience.

This article has been cited by other articles:

				S. Basaria and A. S. Dobs Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752. [Abstract] [Full Text] [PDF]

				J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women J. Neurosci., October 11, 2006; 26(41): 10332 - 10348. [Full Text] [PDF]

				W. Arlt Androgen therapy in women Eur. J. Endocrinol., January 1, 2006; 154(1): 1 - 11. [Abstract] [Full Text] [PDF]

				A. B. Singh, M. L. Lee, I. Sinha-Hikim, M. Kushnir, W. Meikle, A. Rockwood, S. Afework, and S. Bhasin Pharmacokinetics of a Testosterone Gel in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 136 - 144. [Abstract] [Full Text] [PDF]

				G. D. Braunstein, D. A. Sundwall, M. Katz, J. L. Shifren, J. E. Buster, J. A. Simon, G. Bachman, O. A. Aguirre, J. D. Lucas, C. Rodenberg, et al. Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial Arch Intern Med, July 25, 2005; 165(14): 1582 - 1589. [Abstract] [Full Text] [PDF]

				D. S. Guzick Can Postmenopausal Women Patch Up Their Sex Lives With Testosterone? Obstet. Gynecol., May 1, 2005; 105(5): 938 - 940. [Full Text] [PDF]

				H. B Bosworth Depression increases in women during early to late menopause but decreases after menopause Evid. Based Ment. Health, August 1, 2004; 7(3): 90 - 90. [Full Text] [PDF]

				K. R Ragucci and N. S Culhane Treatment of Female Sexual Dysfunction Ann. Pharmacother., April 1, 2003; 37(4): 546 - 555. [Abstract] [Full Text] [PDF]

				H. B. Bosworth, L. A. Bastian, M. N. Kuchibhatla, D. C. Steffens, C. M. McBride, C. S. Skinner, B. K. Rimer, and I. C. Siegler Depressive Symptoms, Menopausal Status, and Climacteric Symptoms in Women at Midlife Psychosom Med, July 1, 2001; 63(4): 603 - 608. [Abstract] [Full Text] [PDF]

				D. S. Guzick and K. Hoeger Sex, Hormones, and Hysterectomies N. Engl. J. Med., September 7, 2000; 343(10): 730 - 731. [Full Text]